Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety of DNP007 in Healthy Subjects — Stella

Home/Liver Transplant Rejection/Safety of DNP007 in Healthy Subjects

View on ClinicalTrials.gov

Recruiting

Back to Liver Transplant Rejection trials

Safety of DNP007 in Healthy Subjects

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

South Korea

Seoul National University Hospital, Seoul

Key details

Phase

Early testing

Sponsor

Seoul National University Hospital

Enrollment target

~12 participants

Started

June 2024

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years – 55 Years

Sex

Male only

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.